A Robust Portfolio of Cancer Clinical Trials
More than 200 active clinical trials give eligible patients access to the latest advances in cancer treatment.
Adult Clinical Trials
For patients considering a clinical trial, the Froedtert & MCW Cancer Network offers studies across a broad range of cancer types and stages of disease.
Pediatric Clinical Trials
Children’s Wisconsin offers clinical trials through the MACC Fund Center for Cancer and Blood Disorders, giving eligible children and families access to new treatment options.
Physician Referrals
MCW Physician ACCESS (All Cancer Enrolling Studies) provides physicians with information about actively enrolling adult and pediatric cancer clinical trials for their patients.
A National Role in Cancer Clinical Research
As one of only 32 academic institutions nationwide selected by the National Cancer Institute as a Lead Academic Participating Site, the MCW Cancer Center plays a significant role in the National Clinical Trials Network. MCW investigators help develop and lead large-scale clinical trials, contribute scientific expertise to national research committees and collaborate with cancer researchers across the country, while expanding access to NCI-supported clinical trials for patients in Wisconsin through the Froedtert & MCW Cancer Network.
Translational Research Units
Clinical Research Support
Behind every clinical trial is a team of people and resources that help move a study from an idea to an active trial. The MCW Cancer Center provides investigators with support throughout that process, including protocol development, scientific review, study activation and trial management.
- Disease-Oriented Teams
- Clinical Trials Office
- Institutional Review Board
- Scientific Review Committee
- Translational Council
Innovative Neuroimaging Technique Could Improve Outcomes for Patients with Glioblastoma
An innovative approach known as radiopathomic mapping combines advanced imaging technology with artificial intelligence to provide a more accurate and comprehensive understanding of how tumors evolve over time, leading to better, more targeted treatments for patients.
MCW Cancer Center Launches MyeloMATCH to Advance Precision Medicine for Myeloid Cancers
The MCW Cancer Center’s Clinical Trials Office recently activated the phase 2 MyeloMATCH screening study, that tests patients’ blood and bone marrow for biomarkers to guide treatment decisions and match them to personalized clinical trials.
PROTECT-PANC Trial Evaluates Precision Medicine Strategies in Patients with Pancreatic Cancer
The fast-track trial bolsters MCW’s dedication to advancing precision medicine strategies across a spectrum of cancer types.